Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LIV by WellNow vs TelePeptide

LIV by WellNow
Graded #262

Higher grade

vs+0.6000000000000014
TelePeptide
Graded #273

Lower grade

The verdict

LIV by WellNow takes it — 62.9/100 to 62.3/100, but only just.

LIV by WellNow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss. TelePeptide is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLIV by WellNow +7
51
44
Dose & formulationTelePeptide +2
73
75
Clinical oversightTelePeptide +8
79
87
Labs & monitoringTelePeptide +2
52
54
FulfillmentTelePeptide +14
63
77
Contract termsLIV by WellNow +35
55
20
LIV by WellNow · left barTelePeptide · right bar

The numbers

MetricLIV by WellNowTelePeptide
WeighScore62.9/10062.3/100
GradeCC
Scorecard rank#262#273
Semaglutide$279/mo$199/mo (starting dose, annual plan, compounded oral)
TirzepatideNot disclosed$219/mo (starting dose, annual plan, compounded oral)
Coverage5 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide
TelePeptide

Graded #273 · C

Strengths

  • LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
  • All-inclusive from $169/mo annual — physician eval + Rx + medication + shipping, no hidden fees
  • Broadest formulation menu: injectable sema/tirz, oral dissolvable tablets, sema+naltrexone, microdose combos
  • 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
  • 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime

Where it loses points

  • Compounded medications are not FDA-approved; no pharmacy partner named publicly
  • Monthly billing costs more — $199/mo (monthly) vs $169/mo (annual) for semaglutide injectable; best rate requires annual prepay
  • Labs not included in any plan
  • Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
  • Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard